Gilead Sciences
GILD
#129
Rank
HK$1.170 T
Marketcap
HK$943.31
Share price
-1.14%
Change (1 day)
32.75%
Change (1 year)

Gilead Sciences (GILD) - Cash on Hand

Cash on Hand as of September 2025 : HK$57.18 Billion

According to Gilead Sciences's latest financial reports the company has HK$57.18 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Gilead Sciences - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31HK$89.80 B58.3%
2023-12-31HK$56.73 B13.72%
2022-12-31HK$49.88 B-1.87%
2021-12-31HK$50.84 B-11.47%
2020-12-31HK$57.42 B-69.72%
2019-12-31HK$189.65 B-19.51%
2018-12-31HK$235.62 B18.22%
2017-12-31HK$199.30 B116.07%
2016-12-31HK$92.24 B-18.53%
2015-12-31HK$113.21 B44.12%
2014-12-31HK$78.55 B375.18%
2013-12-31HK$16.53 B14.53%
2012-12-31HK$14.43 B-81.23%
2011-12-31HK$76.89 B370.81%
2010-12-31HK$16.33 B27.12%
2009-12-31HK$12.84 B-7.12%
2008-12-31HK$13.83 B51.38%
2007-12-31HK$9.13 B25.41%
2006-12-31HK$7.28 B-59.34%
2005-12-31HK$17.91 B83.86%
2004-12-31HK$9.74 B77.83%
2003-12-31HK$5.48 B-25.43%
2002-12-31HK$7.34 B61.7%
2001-12-31HK$4.54 B13.62%
2000-12-31HK$4.00 B74.9%
1999-12-31HK$2.28 B191.99%
1998-12-31HK$0.78 B215.86%
1997-12-31HK$0.24 B-75.71%
1996-12-31HK$1.02 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Amgen
AMGN
HK$73.49 B 28.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
HK$48.92 B-14.45%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$44.13 B-22.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
HK$9.94 B-82.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$30.81 B-46.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$116.60 B 103.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$144.44 B 152.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$77.14 B 34.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$141.73 B 147.84%๐Ÿ‡บ๐Ÿ‡ธ USA